Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT03925714

PHASE3

Impact of P53 and SIRT1 in Type 2 Diabetes

Sponsor: Sherief Abd-Elsalam

View on ClinicalTrials.gov

Summary

Investigating the impact of p53 and SIRT1 in the development of type 2 DM

Official title: Investigating the Impact of p53 and SIRT1 in the Development of Type 2 DM Through the Treatment of Prediabetic Individuals by Either Nigetella Salivata or Metformin

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

Start Date

2019-04-01

Completion Date

2028-12

Last Updated

2019-04-24

Healthy Volunteers

Conditions

Interventions

OTHER

life style

life sryle control only

DRUG

Metformin

metformin twice daily

DRUG

Nigetella salivata

NS twice daily

Locations (1)

Sherief Abd-Elsalam

Cairo, Egypt